Cybersecurity
Medtech Insight talked with GE HealthCare’s chief AI officer Parminder “Parry” Bhatia at HLTH about the firm’s new CareIntellect for Oncology offering to help clinicians make efficient use of multimodal patient data, his vision for projects within AI Innovation Lab, and the future of AI in health care.
Recognizing October as cybersecurity awareness month, the US FDA has added new publications to its list of resources concerning the cybersecurity of medical devices.
Medtech Insight was on the ground at HLTH looking for innovative companies. Learn about seven start-ups using AI to help physicians detect conditions including prostate and breast cancers, seizures and heart failure; assess patients for cognitive decline validate and deploy algorithms, and monitor patients in and out of the hospital.
The commission's recently reelected president also wants the new commission to evaluate the need for potential changes to the medtech regulations.
Now European businesses are returning to “normal” after the summer break, they will find key developments have occurred in the EU during the traditional holiday season.
This week, Change Healthcare admittedi ts February breach revealed sensitive information like medical diagnoses and Social Security Numbers; the Coalition for Health Artificial Intelligence released its Assurance Standards Guide and Reporting Checklist for developers; and the FDA announced public meetings in July on IVD classification, the Home as a Health Care Hub initiative, and device sterilization.
Device manufacturers still have a low level of cybersecurity maturity, but larger companies seem to be doing better than smaller ones.
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operations can hinder that. We talk about the EU’s AI act, the speed of digital transformation, cybersecurity incentives, and how principle-based regulations are better than prescriptive ones.
At the recent Precision Med Tri-Con conference, health care leaders and AI enthusiasts Eric Topol and Doug Flora discussed how AI integration will change the way doctors practice medicine and patients receive care.
Medical device cybersecurity is a part of a larger ecosystem that should not—and cannot—be ignored.
Risk-based AI regulations and data modernization are just a few of the top policy priorities from thought leaders attending the largest health care technology professional gathering in the world.
Draft guidance from the US Food and Drug Administration details what the agency wants to see to demonstrate cybersecurity in connected devices during premarket submissions.
Systems from Change Healthcare are experiencing disruptions for the seventh day in a row after a ransomware attack on parent company UnitedHealth Group.
HHS publishes a new website and releases its essential and enhanced voluntary cybersecurity performance goals.
This week, the FDA extended a comment period on digital health tools to detect diabetes; Theradaptive launched a trial of its spinal fusion device; and devices from Hologic and GE Healthcare won FDA clearance.
As 2024 began, the clamor of voices calling for regulatory reform, including a new EU governance structure for medical devices, had grown to fever pitch. Hot news in January shows how progress is being made. But the likely imminent adoption of the EU’s AI Act could present new issues.
The Office of Strategic Partnerships and Technology Innovation is being expanded to include five divisions, including the Digital Health Center of Excellence.
A new annual report argues that last year was both transformative and historic for the US FDA’s Center for Devices and Radiological Health. The center authorized the highest number of novel medical devices in history while turning the corner on the pandemic.
Views from medtech industry leaders and investors on the most significant uncertainties and opportunities facing the sector in 2024.
A December report from the GAO urged the FDA and CISA to update a 2018 agreement for medical device security, a recommendation both agencies agreed with.